Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.89 USD | -5.25% |
|
-6.47% | -88.37% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.